Advertisement

Topics

KuDOS Pharmaceuticals Limited Company Profile

00:17 EDT 23rd September 2018 | BioPortfolio

KuDOS Pharmaceuticals is a leader in the discovery and development of novel small molecule drugs that target DNA repair and related systems for the treatment f human diseases, in particular cancer. The company was founded by Professor Stephen Jackson of the Wellcome/Cancer Research UK Institute of the University of Cambridge, UK, an internationally renowned scientist in the field of DNA repair.

The company, including its subsidiary, ChemOvation Ltd currently employs 60 people.



KuDOS Pharmaceuticals has identified a number of naturally occurring DNA repair mechanisms and proteins that are fundamental to the control of cell growth and cell death. Whilst primarily focused on the discovery and development of novel therapeutic agents for use in cancer therapy, DNA repair inhibitors can also be used in the treatment of viral infections, ischaemia and immunosuppression.



Since May 1999, KuDOS Pharmaceuticals has established a strong scientific platform that has resulted in the identification of several new classes of promising drug candidates targeted at DNA repair enzymes for the treatment of cancer. KuDOS’ leading product, PaTrin-2, is planned to enter Phase II clinical trials in melanoma and colorectal cancer by 3-4Q 2002. AQ4N, a hypoxic cell cytotoxin, is currently in Phase I evaluation.



Other products are entering pre-clinical studies with the aim of initiating Phase I clinical trials by 2Q 2003/1Q 2004.



Each of KuDOS’ products is based on a detailed molecular understanding of tumour cells and will enhance efficacy of ionising radiation and major chemotherapy regimen.



Product portfolio:



PaTrin-2: Phase II commencing Q4 2002



AQ4N: Phase I ongoing



DNA-PK/ATM inhibitor: Pre-clinical development commencing Q2/3 2002



PARP inhibitor: Pre-clinical development commencing Q3/4 2002



KuDOS Pharmaceuticals has a range of products for development as cancer treatments and will take these forward to Phase II clinical trials prior to partnering products with major pharmaceutical companies for product approval and commercialisation. Applications for other than cancer treatment will be out-licensed at an earlier stage.

Location

327, Cambridge Science Park, Milton Road,
Cambridge
Cambridgeshire
CB4 0WG
United Kingdom

Contact

Phone: 01223 719719
Fax: 01223 719720
Email: jbward@kudospharma.co.uk


News Articles [357 Associated News Articles listed on BioPortfolio]

Opinion: What does PBM stand for? In Ohio (and elsewhere), it’s programs bilking millions

Kudos to the Columbus Dispatch for shining much-needed light on the inner workings of pharmacy benefit managers.

Innovation Pharmaceuticals Views Brilacidin-OM as Clearly Differentiated Compared to Limited Competition for Preventing Severe Oral Mucositis

BEVERLY, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide shareholders wit...

UK's Artios raises $84m to further DDR drug research

UK biotech Artios has raised around $84 million in a fresh round of fundraising, allowing it to develop a pipeline of DNA Damage Response-based (DDR) cancer treatments. Artios’ management team work...

A hyped news release gets revised at ASCO: Did it lead to improved coverage from journalists?

We often write about the problems arising from hyped news releases coming out of medical conferences. But I don’t think we’ve ever written about an over-the-top news release getting toned ...

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Quotient Limited appoints Franz Walt as Chief Executive Officer

JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executi...

PubMed Articles [142 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Clinical Trials [224 Associated Clinical Trials listed on BioPortfolio]

Kansas University DHA Outcome Study (KUDOS) Follow-Up

This is a continuation study to KUDOS (NCT00266825). The purpose of this study is to follow-up with participants on the original study to determine if the effects of increasing DHA intake...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [1408 Associated Companies listed on BioPortfolio]

KuDOS Pharmaceuticals Ltd

KuDOS Pharmaceuticals Limited holds a leading position in the discovery and development of drugs based upon the science of DNA damage sensing, signalling and repair to address unmet medical needs in c...

KuDOS Pharmaceuticals Limited

KuDOS Pharmaceuticals is a leader in the discovery and development of novel small molecule drugs that target DNA repair and related systems for the treatment f human diseases, in particular cancer. T...

Ranbaxy Pharmaceuticals Inc.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida USA, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India’s largest pharmaceutical comp...

Lupin Pharmaceuticals Inc.

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, and is the 4th largest pharmaceutical company in the U.S. based on prescriptions filled. To...

J. B. CHEMICALS & PHARMACEUTICALS LIMITED

J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India’s fastest growing, professionally managed, global pharmaceutical companies manufacturing a wide range of innovative specialty medicines...

More Information about "KuDOS Pharmaceuticals Limited" on BioPortfolio

We have published hundreds of KuDOS Pharmaceuticals Limited news stories on BioPortfolio along with dozens of KuDOS Pharmaceuticals Limited Clinical Trials and PubMed Articles about KuDOS Pharmaceuticals Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of KuDOS Pharmaceuticals Limited Companies in our database. You can also find out about relevant KuDOS Pharmaceuticals Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record